William Blair & Company’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,353
| Closed | -$368K | – | 1884 |
|
|
2022
Q1 | $368K | Buy |
19,353
+4,575
| +31% | +$87K | ﹤0.01% | 1281 |
|
|
2021
Q4 | $392K | Buy |
14,778
+1,803
| +14% | +$47.8K | ﹤0.01% | 1311 |
|
|
2021
Q3 | $533K | Sell |
12,975
-30
| -0.2% | -$1.23K | ﹤0.01% | 1137 |
|
|
2021
Q2 | $737K | Sell |
13,005
-45
| -0.3% | -$2.55K | ﹤0.01% | 1017 |
|
|
2021
Q1 | $548K | Buy |
13,050
+1,350
| +12% | +$56.7K | ﹤0.01% | 1088 |
|
|
2020
Q4 | $820K | Hold |
11,700
| – | – | ﹤0.01% | 926 |
|
|
2020
Q3 | $328K | Buy |
11,700
+900
| +8% | +$25.2K | ﹤0.01% | 1108 |
|
|
2020
Q2 | $319K | Buy |
10,800
+150
| +1% | +$4.43K | ﹤0.01% | 1069 |
|
|
2020
Q1 | $211K | Sell |
10,650
-600
| -5% | -$11.9K | ﹤0.01% | 1149 |
|
|
2019
Q4 | $333K | Hold |
11,250
| – | – | ﹤0.01% | 1137 |
|
|
2019
Q3 | $256K | Sell |
11,250
-3,283
| -23% | -$74.7K | ﹤0.01% | 1181 |
|
|
2019
Q2 | $360K | Hold |
14,533
| – | – | ﹤0.01% | 1094 |
|
|
2019
Q1 | $355K | Sell |
14,533
-938
| -6% | -$22.9K | ﹤0.01% | 1086 |
|
|
2018
Q4 | $352K | Buy |
15,471
+2,171
| +16% | +$49.4K | ﹤0.01% | 1034 |
|
|
2018
Q3 | $423K | Buy |
13,300
+1,700
| +15% | +$54.1K | ﹤0.01% | 1014 |
|
|
2018
Q2 | $416K | Buy |
+11,600
| New | +$416K | ﹤0.01% | 1009 |
|